These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8934608)

  • 21. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
    Leibowitz G; Cerasi E
    Diabetologia; 1996 May; 39(5):503-14. PubMed ID: 8739909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinically important effects of oral antidiabetic drug interactions].
    Drzewoski J; Kopff B
    Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of metformin in treatment of diabetes mellitus.
    Vigneri R; Goldfine ID
    Diabetes Care; 1987; 10(1):118-22. PubMed ID: 3552509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacotherapy of type 2 diabetes mellitus.
    Rendell MS; Kirchain WR
    Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".
    Heine RJ
    Horm Metab Res; 1996 Sep; 28(9):522-6. PubMed ID: 8911991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic optimisation of oral hypoglycaemic therapy.
    Marchetti P; Giannarelli R; di Carlo A; Navalesi R
    Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
    Jennings PE
    Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
    Wurm R; Resl M; Neuhold S; Prager R; Brath H; Francesconi C; Vila G; Strunk G; Clodi M; Luger A; Pacher R; Hülsmann M
    Heart; 2016 Oct; 102(19):1544-51. PubMed ID: 27226327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.
    Stowers JM; Borthwick LJ
    Drugs; 1977 Jul; 14(1):41-56. PubMed ID: 328260
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 40. Rational use of oral hypoglycaemic drugs.
    Taft P
    Drugs; 1979 Feb; 17(2):134-9. PubMed ID: 456290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.